Janus Henderson Group’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $368K | Hold |
39,335
| – | – | ﹤0.01% | 2090 |
|
2025
Q1 | $518K | Hold |
39,335
| – | – | ﹤0.01% | 1941 |
|
2024
Q4 | $520K | Hold |
39,335
| – | – | ﹤0.01% | 2013 |
|
2024
Q3 | $757K | Hold |
39,335
| – | – | ﹤0.01% | 1804 |
|
2024
Q2 | $808K | Sell |
39,335
-9,613
| -20% | -$197K | ﹤0.01% | 1733 |
|
2024
Q1 | $1.16M | Buy |
48,948
+22,501
| +85% | +$535K | ﹤0.01% | 1560 |
|
2023
Q4 | $572K | Sell |
26,447
-39
| -0.1% | -$843 | ﹤0.01% | 1925 |
|
2023
Q3 | $384K | Buy |
26,486
+6
| +0% | +$87 | ﹤0.01% | 2068 |
|
2023
Q2 | $554K | Sell |
26,480
-76
| -0.3% | -$1.59K | ﹤0.01% | 1926 |
|
2023
Q1 | $561K | Buy |
+26,556
| New | +$561K | ﹤0.01% | 1947 |
|
2021
Q2 | – | Sell |
-141,325
| Closed | -$3.16M | – | 1666 |
|
2021
Q1 | $3.16M | Buy |
141,325
+10,867
| +8% | +$243K | ﹤0.01% | 1101 |
|
2020
Q4 | $2.9M | Buy |
+130,458
| New | +$2.9M | ﹤0.01% | 1065 |
|